Filter
836
Text search:
pharmaceutical
regulations
Featured
71
224
Language
Document type
373
184
146
50
50
12
10
6
3
1
1
Countries
47
32
26
26
24
23
23
19
19
18
18
17
15
14
14
14
13
12
11
11
11
9
9
8
8
8
7
6
6
6
5
5
5
5
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
384
43
33
26
24
15
6
Toolboxes
133
91
72
34
26
21
19
18
18
16
15
12
12
12
11
9
8
6
5
2
2
2
2
1
PowerPoint slides outlining the National Pharmacy Council (NPC) of Rwanda
Full eHandbook under: http://www.msh.org/resources/health-systems-in-action-an-ehandbook-for-leaders-and-managers
Effective supply management has the potential to make a powerful contribution to the reliable availability of essential medicines, which are a crucial part of the delivery of highqualit
...
Updated with information on Ebola virus disease and Middle East respiratory syndrome coronavirus
A wide variety of health events ranging in severity may occur related to air transport, requiring different responses or, perhaps, no response at all. The target audience for this guidance document incl
...
This joint ECDC-European Union Aviation Safety Agency (EASA) document aims to support Member States in determining a coordinated approach to reduce the risks related to the movement of people by air within and between the EU/EEA countries and the UK in the context of the COVID-19 pandemic, noting th
...
International Journal of Basic & Clinical Pharmacology 5(6):2290-2294
DOI: 10.18203/2319-2003.ijbcp20164081
WHO Model Formulary
recommended
For each medicine the Formulary provides information on use, dosage, adverse effects, contraindications and warnings, supplemented by guidance on selecting the right medicine for a range of conditions
Documentation of Best Practices and Bottlenecks to Program Implementation in Senegal
SUMMARY REPORT
Accessed at March 2014
Nosocomial or health-facility-acquired infections are a serious issue, representing one of the most significant causes of morbidity and mortality in healthcare systems and consuming many scarce resources, especially in developing countries. Although much has been done, particularly in the hospital s
...
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
First Revised Edition
March 2000
